Suppr超能文献

在不情愿的时代协商疫苗接种接受度。

Negotiating vaccine acceptance in an era of reluctance.

机构信息

Department of Infectious Disease Epidemiology; London School of Hygiene & Tropical Medicine; London, UK.

出版信息

Hum Vaccin Immunother. 2013 Aug;9(8):1779-81. doi: 10.4161/hv.25932. Epub 2013 Jul 29.

Abstract

Studies to better understand the determinants of vaccine acceptance have expanded to include more investigation into dynamics of individual decision-making as well as the influences of peers and social networks. Vaccine acceptance is determined by a range of factors, from structural issues of supply, costs and access to services, as well as the more demand-side determinants. The term vaccine hesitancy is increasingly used in the investigation of demand-side determinants, moving away from the more polarized framing of pro- and anti-vaccine groups to recognizing the importance of understanding and engaging those who are delaying vaccination, accepting only some vaccines, or who are yet undecided, but reluctant. As hesitancy is a state of indecision, it is difficult to measure, but the stage of indecision is a critical time to engage and support the decision-making process. This article suggests modes of investigating the determinants of vaccine confidence and levers of vaccine acceptance toward better engagement and dialogue early in the process of decision-making. Pressure to vaccinate can be counter-productive. Listening and dialog can support individual decision-making and more effectively inform the public health community of the issues and concerns influencing vaccine hesitancy.

摘要

为了更好地了解疫苗接种接受度的决定因素,研究已经扩展到更深入地研究个人决策的动态以及同伴和社交网络的影响。疫苗接种接受度由一系列因素决定,包括供应、成本和服务获取等结构性问题,以及更多的需求方决定因素。在需求方决定因素的研究中,越来越多地使用“疫苗犹豫”一词,这一概念摒弃了对支持和反对疫苗接种群体更为两极化的描述,转而认识到理解和接触那些推迟接种、只接受某些疫苗或尚未做出决定但犹豫不决的人的重要性。由于犹豫是一种犹豫不决的状态,因此很难衡量,但犹豫不决的阶段是参与和支持决策过程的关键时期。本文提出了一些调查疫苗信心决定因素和接受疫苗的杠杆的模式,以便在决策过程的早期更好地参与和对话。强制接种可能会适得其反。倾听和对话可以支持个人决策,并更有效地让公共卫生界了解影响疫苗犹豫的问题和关注点。

相似文献

1
Negotiating vaccine acceptance in an era of reluctance.
Hum Vaccin Immunother. 2013 Aug;9(8):1779-81. doi: 10.4161/hv.25932. Epub 2013 Jul 29.
2
Vaccine hesitancy: an overview.
Hum Vaccin Immunother. 2013 Aug;9(8):1763-73. doi: 10.4161/hv.24657. Epub 2013 Apr 12.
4
Vaccine hesitancy: Definition, scope and determinants.
Vaccine. 2015 Aug 14;33(34):4161-4. doi: 10.1016/j.vaccine.2015.04.036. Epub 2015 Apr 17.
5
Public trust and vaccine acceptance--international perspectives.
Hum Vaccin Immunother. 2013 Aug;9(8):1774-8. doi: 10.4161/hv.24961. Epub 2013 Jun 3.
6
The rise (and fall?) of parental vaccine hesitancy.
Hum Vaccin Immunother. 2013 Aug;9(8):1755-62. doi: 10.4161/hv.25085. Epub 2013 Jun 6.
7
Vaccine hesitancy among mobile pastoralists in Chad: a qualitative study.
Int J Equity Health. 2018 Nov 14;17(1):167. doi: 10.1186/s12939-018-0873-2.
8
Vaccine hesitancy and healthcare providers.
Vaccine. 2016 Dec 20;34(52):6700-6706. doi: 10.1016/j.vaccine.2016.10.042. Epub 2016 Oct 31.
10
'Hesitant compliers': Qualitative analysis of concerned fully-vaccinating parents.
Vaccine. 2018 Oct 22;36(44):6459-6463. doi: 10.1016/j.vaccine.2017.09.088. Epub 2017 Oct 12.

引用本文的文献

1
Influenza vaccine hesitancy among healthcare workers in a Northeastern province in Thailand: Findings of a cross-sectional survey.
PLoS One. 2024 Sep 19;19(9):e0310761. doi: 10.1371/journal.pone.0310761. eCollection 2024.
4
Prevalence and predictors of vaccine hesitancy among mothers of under-five children: A hospital-based cross-sectional study.
J Educ Health Promot. 2023 Jan 31;12:34. doi: 10.4103/jehp.jehp_687_22. eCollection 2023.
5
Cultivating COVID-19 Vaccine Confidence in Pharmacy Professionals.
Pharmacy (Basel). 2023 Mar 7;11(2):50. doi: 10.3390/pharmacy11020050.
6
Effects of mobile APP for immunization on vaccination compliance of migrant children in southwest China: A community trial study.
Hum Vaccin Immunother. 2022 Dec 30;18(7):2135853. doi: 10.1080/21645515.2022.2135853. Epub 2022 Dec 5.
7
How to counter the anti-vaccine rhetoric: Filling information voids and building resilience.
Hum Vaccin Immunother. 2022 Nov 30;18(6):2095825. doi: 10.1080/21645515.2022.2095825. Epub 2022 Jul 8.
8
The Vaccination Concerns in COVID-19 Scale (VaCCS): Development and validation.
PLoS One. 2022 Mar 14;17(3):e0264784. doi: 10.1371/journal.pone.0264784. eCollection 2022.
9
Knowledge about COVID-19 vaccine and vaccination in Vietnam: A population survey.
J Am Pharm Assoc (2003). 2022 Jul-Aug;62(4):1197-1205.e4. doi: 10.1016/j.japh.2022.01.014. Epub 2022 Jan 19.

本文引用的文献

1
Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines.
Lancet Infect Dis. 2013 Jul;13(7):606-13. doi: 10.1016/S1473-3099(13)70108-7. Epub 2013 May 13.
2
Opportunities and challenges of Web 2.0 for vaccination decisions.
Vaccine. 2012 May 28;30(25):3727-33. doi: 10.1016/j.vaccine.2012.02.025. Epub 2012 Feb 22.
4
Addressing the vaccine confidence gap.
Lancet. 2011 Aug 6;378(9790):526-35. doi: 10.1016/S0140-6736(11)60678-8. Epub 2011 Jun 12.
5
Target the fence-sitters.
Nature. 2011 May 26;473(7348):443-5. doi: 10.1038/473443a.
6
"Vaccine hesitancy" means scientists need to be more honest about risks.
BMJ. 2011 Apr 15;342:d2479. doi: 10.1136/bmj.d2479.
7
Development of a survey to identify vaccine-hesitant parents: the parent attitudes about childhood vaccines survey.
Hum Vaccin. 2011 Apr;7(4):419-25. doi: 10.4161/hv.7.4.14120. Epub 2011 Apr 1.
8
A crisis of public confidence in vaccines.
Sci Transl Med. 2010 Dec 8;2(61):61mr1. doi: 10.1126/scitranslmed.3001738.
9
Public health response to influenza A(H1N1) as an opportunity to build public trust.
JAMA. 2010 Jan 20;303(3):271-2. doi: 10.1001/jama.2009.2023.
10
Protecting public trust in immunization.
Pediatrics. 2008 Jul;122(1):149-53. doi: 10.1542/peds.2008-0987.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验